US OptionsDetailed Quotes

HALO250417C70000

Watchlist

0.05
0.000.00%

15min DelayClose Apr 17 15:55 ET

0.00High0.00Low

Halozyme Therapeutics Stock Discussion

Teddy123

Apr 11 15:27

Halozyme Announces FDA Approval of argenx's VYVGART® Hytrulo Prefilled Syringe Co-Formulated with ENHANZE® for Self-Injection for Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating

$Halozyme Therapeutics (HALO.US)$
Game-Changing FDA Approval: New Self-Injectable Treatment Transforms Rare Disease Care

Teddy123

Apr 9 20:46

European Commission Approved Subcutaneous DARZALEX® (daratumumab)-based Quadruplet Regimen for the Treatment of Patients with Newly Diagnosed Multiple Myeloma, Regardless of Transplant Eligibility

$Halozyme Therapeutics (HALO.US)$ is
Major EU Approval: Revolutionary Subcutaneous Multiple Myeloma Treatment Gets Green Light

Teddy123

Apr 7 21:53

European Commission Approves Subcutaneous RYBREVANT® (amivantamab) Co-Formulated with ENHANZE® for the Treatment of Patients with Advanced EGFR-Mutated Non-Small Cell Lung Cancer

$Halozyme Therapeutics (HALO.US)$
Major EU Victory: Halozyme's ENHANZE Tech Gets Green Light for Advanced Lung Cancer

Noah Khos

Feb 18 06:42

$Halozyme Therapeutics (HALO.US)$ potential $60 post earnings report on 18th

Meltyy

May 22, 2024 15:41

Clinical Updates💉
⇒ $Larimar Therapeutics (LRMR.US)$ 🟢
‣ FDA removes partial clinical hold
‣ Nomlabofusp (CTI-1601) #FA
‣ Protein replacement therapy
‣ Interim data from OLE in Q4 '24 🔔
Clinical readouts 📢
⇒ $Citius Pharmaceuticals (CTXR.US)$ 🟢
‣ Positive Ph3 topline results
‣ Mino-Lok® #CLABSI #CRBSI
‣ Antibiotic lock solution
‣ Overall treatment success in 57.1% patients
Regulatory Update🎯
⇒ $Halozyme Therapeutics (HALO.US)$ $Bristol-Myers Squibb (BMY.US)$
‣ FDA Reassigned PDUFA data to 12/29/24
‣ Subcutane...

Moomoo AI

Feb 19, 2024 19:59

EPS growth outshines yearly share price gain, hinting at cautious market sentiment. Despite recent sell-off, long-term investors see 16% annual return over five years, suggesting sell-off may be an opportunity for those seeking long-term growth.

Halozyme Therapeutics' (NASDAQ:HALO) Investors Will Be Pleased With Their Impressive 107% Return Over the Last Five Years

Moomoo AI

Dec 25, 2023 19:09

The insider stock selling at Halozyme Therapeutics could raise concerns among shareholders. However, the fact that insiders maintain a considerable amount of shares might suggest some level of alignment between management and smaller shareholders.

Halozyme Therapeutics Insiders Sell US$1.8m Of Stock, Possibly Signalling Caution

Moomoo AI

Nov 28, 2023 18:48

Confidence in Halozyme Therapeutics is suggested due to solid EPS growth and significant insider investment aligning with shareholders' interests.

Should You Be Adding Halozyme Therapeutics (NASDAQ:HALO) To Your Watchlist Today?

Movers and Shakers

May 10, 2023 21:06

Columns Today's Pre-Market Stock Movers: ABNB, RIVN, AFRM, SPCE and More

Gapping up
$Rivian Automotive (RIVN.US)$ +6% (The company reported a first-quarter loss that was narrower than expected. Rivian also said it's still on track to meet a 50,000-vehicle production target for 2023.)
$Celsius Holdings (CELH.US)$ +11.1% (The company posted a strong earnings report. Celsius posted 40 cents in earnings per share for the first quarter, more than doubling the 19-cent consensus estimate of analysts polled by Str...

Mooers Radar

Jan 12, 2023 17:39

Columns US Top Gap Ups and Downs on 1/11: SONY, TOLL, FERG, NVO and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after the previous market closed (gaps range from large to small):
Gap Ups
1. $Topbuild (BLD.US)$ - up 2.7%
2. $Atlassian (TEAM.US)$ - up 2.4%
3. $Pool Corp (POOL.US)$ - up 2%
4. $Sony (SONY.US)$ - up 1.9%
5. $Toll Brothers (TOL.US)$ - up 1.8%
6. $Charles River (CRL.US)$ - up 1.4%
7. $Gaming and Leisure Properties Inc (GLPI.US)$ - up 1.4%
8. $WPP PLC (WPP.US)$ - up 1.3%...

+15

No comment yet